Provided by Tiger Trade Technology Pte. Ltd.

Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)

8.50
-0.1100-1.28%
Volume:344.25K
Turnover:2.93M
Market Cap:823.22M
PE:-4.36
High:8.63
Open:8.48
Low:8.41
Close:8.61
52wk High:11.06
52wk Low:3.30
Shares:96.85M
Float Shares:77.97M
Volume Ratio:0.65
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9500
EPS(LYR):-2.5505
ROE:-74.65%
ROA:-42.51%
PB:3.27
PE(LYR):-3.33

Loading ...

Anteris Technologies cleared by ANSM for DurAVR THV trial

TIPRANKS
·
Jun 08

Anteris Technologies Global - Receives French Regulatory Clearance for Duravr Transcatheter Heart Valve Global Trial

THOMSON REUTERS
·
Jun 08

Anteris wins French ANSM clearance for DurAVR transcatheter valve PARADIGM trial

Reuters
·
Jun 08

Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance

GlobeNewswire
·
Jun 08

Change of Director's Interest Notice-AVR.O

Reuters
·
Jun 05

Statement of CDIs on issue - AVR-AVR.O

Reuters
·
Jun 05

Anteris Technologies director Susan Elizabeth Knight acquires 11,000 common shares worth $102,228.50

Reuters
·
Jun 05

Notification of cessation of securities - AVR-AVR.O

Reuters
·
Jun 02

Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL), Cogent Biosciences (COGT) and Anteris Technologies Global Corp. (AVR)

TIPRANKS
·
Jun 01

Anteris Technologies Global Corp-Prospectus Supplement and Sales Agreement

THOMSON REUTERS
·
May 25

Anteris enters TD Cowen equity distribution agreement for up to $250 million stock offering

Reuters
·
May 23

Anteris Technologies Global Corp - to Offer up to $250 Mln of Common Stock Through TD Cowen - SEC Filing

THOMSON REUTERS
·
May 23

Anteris Technologies files Form 3 as director Susan Elizabeth Knight reports no holdings

Reuters
·
May 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (MDT), Immunovant (IMVT) and Anteris Technologies Global Corp. (AVR)

TIPRANKS
·
May 21

Anteris Technologies’ director Stephen Denaro files initial beneficial ownership statement

Reuters
·
May 19

Initial Director's Interest Notice x 2-AVR.O

Reuters
·
May 18

Anteris Techs Glbl Is Maintained at Overweight by Barclays

Dow Jones
·
May 15

Anteris Technologies Global : Barclays Raises Target Price to $18 From $17

THOMSON REUTERS
·
May 15

Barclays Reaffirms Their Buy Rating on Anteris Technologies Global Corp. (AVR)

TIPRANKS
·
May 15

Anteris Technologies price target raised to $18 from $17 at Barclays

TIPRANKS
·
May 15